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Serum procalcitonin levels in patients with
mild community-acquired pneumonia
Serum procalcitonin (PCT) has been described as
a useful parameter for distinguishing various
types of inﬂammation [1]. A recent study in
CMI [2] demonstrated the superiority of PCT for
the differential diagnosis of febrile neutropenia in
comparison with C-reactive protein. In order to
elucidate the value of PCT in comparison with
other parameters for diagnosis in patients with
mild community-acquired pneumonia, we con-
ducted a study in 116 consecutive patients
with community-acquired pneumonia who were
receiving oral antibiotic therapy. Patient demo-
graphics, medical history, signs and symptoms,
X-ray characteristics and laboratory parameters
were recorded. An aetiological diagnosis was
attempted by blood and sputum culture, tests
for Streptococcus pneumoniae (Binax, Portland, ME,
USA) and Legionella pneumophila (Biotest AG,
Dreieich, Germany) urinary antigens, and anti-
body tests for Mycoplasma pneumoniae (ELISA;
Serion Immundiagnostica, Wu¨rzburg, Germany),
Chlamydia pneumoniae (microimmunoﬂuorescence
test; MRL Diagnostics, Cypress, CA, USA) and
Legionella pneumophila (immunoﬂuorescence; loc-
ally prepared L. pneumophila serogroup 1–14 and
Legionella micdadei antigens) in paired samples.
Statistical analysis was performed using SPSS
v. 10.0 (SPSS Inc., Chicago, IL, USA) and Micro-
soft Excel 2000.
Complete data sets were available for 99
patients, and the aetiology was established for
62 patients. Patients with atypical (M. pneumoniae,
C. pneumoniae and L. pneumophila), typical
(S. pneumoniae, Haemophilus inﬂuenzae, Moraxella
catarrhalis) and unknown aetiology differed in
age (p 0.007), chills (p 0.042), dyspnoea (p 0.013),
bronchial breathing (p 0.008), PCT (p 0.021) and
log PCT (p < 0.0001). One of 42 patients with an
atypical aetiology had a PCT level > 0.5 lg ⁄L,
compared with nine of 15 patients in the group
with typical pneumonia. A substantial overlap
was observed between patients with pneumonia
of typical, atypical and unknown aetiology with
respect to C-reactive protein values, white blood
cell counts and the percentage of non-segmented
neutrophils, but not for PCT and log PCT values
(Fig. 1). In comparison with C-reactive protein,
white blood cell and non-segmented neutrophil
counts, only the area under the random operator
characteristic curve for PCT was signiﬁcantly
different from the diagonal line of no predictive
value (p 0.004). There was no difference in PCT
levels for patients classiﬁed in different risk
classes by Fine et al. [3]. The speciﬁcity of tests
for PCT levels in distinguishing between typical
and atypical pneumonia was highest with a cut-
off level of 0.48 lg ⁄L.
We conclude that measurement of PCT levels
seems to be a useful tool to rule out an atypical
aetiology of pneumonia and to limit the use of
broad-spectrum antibiotics. The results outlined
above support the use of PCT as a tool to help
discriminate between patients with lower respir-
atory tract infections who need antibiotics and
those who do not [4].
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Elevated serum transaminases in patients
with Mycoplasma pneumoniae pneumonia
The recent report in CMI by Daxboeck et al. [1]
described a study in which serologically diag-
nosed patients with Mycoplasma pneumoniae
community-acquired pneumonia (CAP) were
compared with 38 patients with Streptococcus
pneumoniae CAP. Increased M. pneumoniae IgM
titres suggest current or recent respiratory tract
infection, but the authors based their diagnosis of
Mycoplasma CAP on ‘highly elevated complement
ﬁxation antibody titres’ which, if unspeciﬁed,
usually indicate IgG immunoglobulins [2]. Eleva-
ted IgG titres indicate past exposure ⁄ infection,
and are not diagnostic of acute infection, although
a > 4-fold increase in IgG titres also suggests
recent infection. The authors reported that serum
alanine transaminase (ALT) levels were increased
in 36% of patients with elevated complement
ﬁxation IgG Mycoplasma titres [1].
Serological diagnosis is fraught with interpre-
tational difﬁculties without clinical correlations.
The report does not provide any description
of extra-pulmonary ﬁndings characteristic of
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Fig. 1. Serum procalcitonin (PCT), log PCT, C-reactive protein, white blood cell (WBC) counts and non-segmented
neutrophils (median, interquartile range, outliers, and extreme cases of individual variables) in patients with typical,
atypical and unknown aetiology of pneumonia.
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